Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue Arcturus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Pipeline Progress Continues Danaher Corporation DHR Q1 2026 Earnings EPS Beats Estimates by 531 Amid Mixed Disclosures ORIC Q1 2026 Earnings NarrowerThanExpected Loss Pipeline Progress Keeps Focus on Key Milestones UUUU Q1 2026 Earnings NarrowerThanExpected Loss Amid Uranium Market Strength BABA Q1 2026 Earnings Massive EPS Miss Shakes Investor Confidence